About this episode

The episode discusses Anthropic's IPO plans, Novo Nordisk's partnership with OpenAI, and advancements in brain sensor technology.

Anthropic adds the Novartis CEO to its board as it gears up for an IPO — and on the same day, Novo Nordisk partners with OpenAI to supercharge drug development. We break down what this healthcare AI land grab means for the industry. Plus, Science Corp (founded by ex-Neuralink co-founder Max Hodak) is preparing to place its first sensor in a human brain, Stanford's latest AI Index reveals a growing disconnect between AI insiders and the public, and Google rolls out AI Skills in Chrome so you can save and reuse your favorite workflows. Get the top 80+ AI Models for $8.99 at AI Box: ⁠⁠https://aibox.ai How I Grow and Scale My Business with AI: https://www.skool.com/aihustle

People in this episode

Host: Jaeden Schafer

Topics covered

• AI
• healthcare
• drug development
• IPO
• brain sensor
• technology

Keywords

• Anthropic
• Novo Nordisk
• OpenAI
• brain sensor
• AI Skills
• drug development
• IPO
• Max Hodak

Mentioned in this episode

Organizations: Anthropic, Novo Nordisk, OpenAI, Science Corp, Stanford, Google

Products: AI Skills, AI Box

More episodes of AI Chat: AI News & Artificial Intelligence

• Cohere Co-Founder Nick Frosst on Enterprise AI and Sovereignty · April 27, 2026 · 32 min
• OpenAI and Microsoft's Split Unveiled · April 27, 2026 · 17 min
• Unveiling ChatGPT 5.5 Today · April 24, 2026 · 16 min
• Innovations in Google’s AI Cloud Strategy · April 22, 2026 · 16 min
• New Apple CEO, OpenAI's New Image Model, Vercel AI Hack · April 21, 2026 · 16 min
• Why Anthropic Is Outperforming OpenAI · April 20, 2026 · 15 min

Explore listener stats, chart rankings, contacts and more on the AI Chat: AI News & Artificial Intelligence podcast page.